About OctoPlus
OctoPlus is a Healthcare company based in Leiden (Netherlands) founded in 1995 by Daan Crommelin and Joost Holthuis, and was acquired by Dr. Reddy's Laboratories in October 2012. Company specializing in formulation and process development of complex injectables. OctoPlus has raised $28.3 million across 4 funding rounds from investors including Dr. Reddy's Laboratories, Life Sciences Partners and SR One. Its chief executive, as recorded, is Jan Egberts. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
OctoPlus is a company offering formulation and process development services for complex injectables. Their service portfolio includes formulation (Liquid and freeze-dried, Lipid-based and Polymer Tech-based formulations), analytical and process (Lyophilization, Emulsification, Homogenisation etc.) development services. OctoPlus has experience in delivery vehicles such as Liposomes, Nanosuspensions, Microspheres and their proprietary PolyActive microspheres technology, which is a degradable polymeric delivery system that helps in making controlled release formulations specifically for injectable protein drugs, which the company claims can increase drug efficacy and reduces side-effects by increasing the half-life of the drug. The company has experience in formulation development for Proteins Antibodies, Peptides, Low Solubles, siRNAs, and Vaccines. OctoPlus claims to have worked on over 50 products, from their own pipeline and mostly from partners especially in the field of depot injections based on polymers. The company was acquired by Dr.Reddys Labs in 2013. They are currently working with Dr.Reddys for the formulation development of complex injectables in oncology and other indications. OctoPlus also works with external partners for developing generic and innovative injectables through Research collaborations, Out-licensing and Co-development partnerships.
- Headquarters Leiden, Netherlands
- Founders Daan Crommelin, Joost Holthuis
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website octoplus.nl/nl/Home
- Social LinkedIn
- Acquired by Dr. Reddy's Laboratories (Oct 2012)
- Total Equity Funding$28.3M (USD)
in 4 rounds
- Latest Funding Round$3.95M (USD), Post-IPO
Apr 2012
- InvestorsDr. Reddy's Laboratories
& 2 more
- Acquired byDr. Reddy's Laboratories
(Oct 2012)
Funding Insights of OctoPlus
OctoPlus has successfully raised a total of $28.3M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $3.95 million completed in April 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $28.3M
- Total Rounds 4
- Last Round Post-IPO — $3.95M
- First Round $28.3M
(Jan 2005)
- Investors Count 2
All 4 funding rounds of OctoPlus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2012 | $3.95M | Post-IPO | – | – | – |
| Sep 2011 | $2.88M | Post-IPO | – | – | – |
| Dec 2010 | $5.27M | Post-IPO | – | – | – |
| Jan 2005 | $28.3M | Series B | – | – |
3 investors in total: 3 institutional.
Investors in OctoPlus
OctoPlus has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Dr. Reddy's Laboratories, Life Sciences Partners and SR One.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
A biotechnology venture capital firm investing in innovative science. | srone.com | |||
Innovative medicines are developed and manufactured globally by the company. | 1984 | drreddys.com | Hyderabad, India |
Investor details for OctoPlus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OctoPlus
4 people are tracked at OctoPlus (4 in leadership).
| Name | Role | Group |
|---|---|---|
Daan Crommelin | Co-Founder | Leadership |
Joost Holthuis | Co-Founder | Leadership |
Jan Egberts | CEO | Leadership |
Mia C. Chen | Co-Founder & CEO | Leadership |
Complete people profiles for OctoPlus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OctoPlus
4 dated milestones of OctoPlus across 17 years, from founding to its latest funding, stage changes and deals.
- Founded OctoPlus is founded.
- Funding First funding round of $28.3M.
- Funding Latest funding round, Post-IPO, of $4.0M.
- Exit Acquired by Dr. Reddy's Laboratories.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OctoPlus
OctoPlus was founded in 1995 and raised its 1st funding round 10 years after it was founded.
OctoPlus is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Jan Egberts is the CEO of OctoPlus, as recorded in our data.
OctoPlus is a funded company, having raised a total of $28.3M across 4 funding rounds to date. The company's 1st funding round was a Series B of $28.3M, raised on Jan 2005.
OctoPlus is a company offering formulation and process development services for complex injectables. Their service portfolio includes formulation (Liquid and freeze-dried, Lipid-based and Polymer Tech-based formulations), analytical and process (Lyophilization, Emulsification, Homogenisation etc.) development services. OctoPlus has experience in delivery vehicles such as Liposomes, Nanosuspensions, Microspheres and their proprietary PolyActive microspheres technology, which is a degradable polymeric delivery system that helps in making controlled release formulations specifically for injectable protein drugs, which the company claims can increase drug efficacy and reduces side-effects by increasing the half-life of the drug. The company has experience in formulation development for Proteins Antibodies, Peptides, Low Solubles, siRNAs, and Vaccines. OctoPlus claims to have worked on over 50 products, from their own pipeline and mostly from partners especially in the field of depot injections based on polymers. The company was acquired by Dr.Reddys Labs in 2013. They are currently working with Dr.Reddys for the formulation development of complex injectables in oncology and other indications. OctoPlus also works with external partners for developing generic and innovative injectables through Research collaborations, Out-licensing and Co-development partnerships.
OctoPlus has 3 investors. Key investors include Dr. Reddy's Laboratories, Life Sciences Partners, and SR One.
Yes. OctoPlus was acquired by Dr. Reddy's Laboratories in October 2012.